Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001307218-25-000003
Filing Date
2025-12-22
Accepted
2025-12-22 18:04:27
Documents
1
Period of Report
2025-12-18

Document Format Files

Seq Description Document Type Size
1 form4-12222025_111224.html 4  
1 form4-12222025_111224.xml 4 4066
  Complete submission text file 0001307218-25-000003.txt   5607
Mailing Address C/O CALLISTO PHARMACEUTICALS, INC. 420 LEXINGTON AVE., SUITE 1609 NEW YORK NY 10170
Business Address
Ross Iain (Reporting) CIK: 0001307218 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39487 | Film No.: 251593708

Mailing Address 12 HAMMERSMITH GROVE OFFICE 205 LONDON United Kingdom W6 7AP
Business Address 12 HAMMERSMITH GROVE OFFICE 205 LONDON United Kingdom W6 7AP 44-0-20-3457 6900
Silence Therapeutics plc (Issuer) CIK: 0001479615 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)